Wound Levobupivacaine Continuous Infusion for Postoperative Analgesia in Living Kidney Donors: Case-Control Study

Abstract Introduction The objective of this study was to evaluate the efficacy of an analgesic regimen based on levobupivacaine continuous infusion into the surgical wound of living kidney donors (LKDs). Patients and Methods Fifty adult LKDs (mean age, 53.1 ± 5.3 years; age range, 52–68 years) were...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Transplantation proceedings 2009-05, Vol.41 (4), p.1128-1131
Hauptverfasser: Sorbello, M, Paratore, A, Morello, G, Tindaro Sidoti, M, Rinzivillo, D, Molino, C, Di Tommaso, C, Parrinello, L, Veroux, P, Corona, D, Giuffrida, G, Zerbo, D, Veroux, M
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1131
container_issue 4
container_start_page 1128
container_title Transplantation proceedings
container_volume 41
creator Sorbello, M
Paratore, A
Morello, G
Tindaro Sidoti, M
Rinzivillo, D
Molino, C
Di Tommaso, C
Parrinello, L
Veroux, P
Corona, D
Giuffrida, G
Zerbo, D
Veroux, M
description Abstract Introduction The objective of this study was to evaluate the efficacy of an analgesic regimen based on levobupivacaine continuous infusion into the surgical wound of living kidney donors (LKDs). Patients and Methods Fifty adult LKDs (mean age, 53.1 ± 5.3 years; age range, 52–68 years) were retrospectively assigned to a no wound infusion (NWI) group (n = 25) or a wound infusion (WI) group (n = 25). At the end of surgery, patients in the WI group received 10 mg intramuscular morphine; a peridural catheter was placed 10 cm between the intercostal muscles fibers close to the lower rib extremity, and a solution of levobupivacaine, 150 mg/100 mL, was started at 5 ml/h−1 . Patients in the NWI group received intramuscular morphine, 10 mg, every 8 hours; intravenous tramadole, 100 mg, was planned as a rescue drug for incidental pain. Pain was measured using a visual analog scale (VAS) ranging from 1 (no pain) to 10 (maximum pain) in both the basal condition (VASb) and during coughing (VASc) at 1 hour after leaving the operating room and 6, 12, and 24 hours thereafter. Results At 1, 6, 12, and 24 hours, VASb values in the NWI vs the WI group were 5.2 vs 3.1, 6.8 vs 4.1, 5.8 vs 4.9 (all p < .01), and 5.4 vs 5.1, respectively, and VASc values were 8.2 vs 6.3, 8.8 vs 5.9, 7.1 vs 5.3, and 6.8 vs 5.1 (all p < .01). Mean VAS score was significantly higher between 1 and 6 hours in the NWI group for all VASb measurements vs VASc values. Tramadole consumption was higher in the NWI group than in the WI group. Conclusions Continuous wound infusion with 5 mL/h−1 levobupivacaine, 1.5 mg/mL−1 , resulted in a safe and effective analgesic protocol in LKDs both in the immediate postoperative period and in the first day after surgery, a result that was more effective than a morphine-tramadole regimen. No adverse effects were recorded, which confirmed the safety of the technique. It is probable that better results could be achieved with dedicated administration devices.
doi_str_mv 10.1016/j.transproceed.2009.03.013
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_733100563</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S004113450900400X</els_id><sourcerecordid>733100563</sourcerecordid><originalsourceid>FETCH-LOGICAL-c464t-97be450b527be1a16e4b38a4a795d469049d095ddbd4e3be65a30ef34defc1893</originalsourceid><addsrcrecordid>eNqNklGL1DAQx4so3nr6FSQIck9dJ03abu9BOPbUO1xQOEXfQppMj6zdZC_TFvbbm7LLcfjkUybMb_4z-Wey7B2HJQdefdguh6g97WMwiHZZADRLEEvg4lm24Kta5EVViOfZAkDynAtZnmWviLaQ7oUUL7Mz3sgKZFMvsodfYfSWbXAK7bh3kzbaeWTr4AfnxzASu_XdSC541oXIvgcawh6jHtyE7Mrr_h7JaeY827jJ-Xv21VmPB3YdfIh0ydaaMJ_VYujZ3TDaw-vsRad7wjen8zz7-fnTj_VNvvn25XZ9tcmNrOSQN3WLsoS2LFLANa9QtmKlpa6b0sqqSeNbSKFtrUTRYlVqAdgJabEzfNWI8-ziqJt8ehiRBrVzZLDvtcf0LlULwQHKSiTy8kiaGIgidmof3U7Hg-KgZsfVVj11XM2OKxAqOZ6K357ajO0u5R5LTxYn4P0J0GR03yUh4-iRK3gtm2pVJu76yGEyZXIYFRmH3qB1Ec2gbHD_N8_Hf2RM77xLnf_gAWkbxph-jRRXVChQd_OOzCsCTYoAfou_tQ-9Cg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>733100563</pqid></control><display><type>article</type><title>Wound Levobupivacaine Continuous Infusion for Postoperative Analgesia in Living Kidney Donors: Case-Control Study</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><creator>Sorbello, M ; Paratore, A ; Morello, G ; Tindaro Sidoti, M ; Rinzivillo, D ; Molino, C ; Di Tommaso, C ; Parrinello, L ; Veroux, P ; Corona, D ; Giuffrida, G ; Zerbo, D ; Veroux, M</creator><creatorcontrib>Sorbello, M ; Paratore, A ; Morello, G ; Tindaro Sidoti, M ; Rinzivillo, D ; Molino, C ; Di Tommaso, C ; Parrinello, L ; Veroux, P ; Corona, D ; Giuffrida, G ; Zerbo, D ; Veroux, M</creatorcontrib><description>Abstract Introduction The objective of this study was to evaluate the efficacy of an analgesic regimen based on levobupivacaine continuous infusion into the surgical wound of living kidney donors (LKDs). Patients and Methods Fifty adult LKDs (mean age, 53.1 ± 5.3 years; age range, 52–68 years) were retrospectively assigned to a no wound infusion (NWI) group (n = 25) or a wound infusion (WI) group (n = 25). At the end of surgery, patients in the WI group received 10 mg intramuscular morphine; a peridural catheter was placed 10 cm between the intercostal muscles fibers close to the lower rib extremity, and a solution of levobupivacaine, 150 mg/100 mL, was started at 5 ml/h−1 . Patients in the NWI group received intramuscular morphine, 10 mg, every 8 hours; intravenous tramadole, 100 mg, was planned as a rescue drug for incidental pain. Pain was measured using a visual analog scale (VAS) ranging from 1 (no pain) to 10 (maximum pain) in both the basal condition (VASb) and during coughing (VASc) at 1 hour after leaving the operating room and 6, 12, and 24 hours thereafter. Results At 1, 6, 12, and 24 hours, VASb values in the NWI vs the WI group were 5.2 vs 3.1, 6.8 vs 4.1, 5.8 vs 4.9 (all p &lt; .01), and 5.4 vs 5.1, respectively, and VASc values were 8.2 vs 6.3, 8.8 vs 5.9, 7.1 vs 5.3, and 6.8 vs 5.1 (all p &lt; .01). Mean VAS score was significantly higher between 1 and 6 hours in the NWI group for all VASb measurements vs VASc values. Tramadole consumption was higher in the NWI group than in the WI group. Conclusions Continuous wound infusion with 5 mL/h−1 levobupivacaine, 1.5 mg/mL−1 , resulted in a safe and effective analgesic protocol in LKDs both in the immediate postoperative period and in the first day after surgery, a result that was more effective than a morphine-tramadole regimen. No adverse effects were recorded, which confirmed the safety of the technique. It is probable that better results could be achieved with dedicated administration devices.</description><identifier>ISSN: 0041-1345</identifier><identifier>EISSN: 1873-2623</identifier><identifier>DOI: 10.1016/j.transproceed.2009.03.013</identifier><identifier>PMID: 19460497</identifier><identifier>CODEN: TRPPA8</identifier><language>eng</language><publisher>Amsterdam: Elsevier Inc</publisher><subject>Adult ; Aged ; Anesthetics, Local - administration &amp; dosage ; Anesthetics, Local - adverse effects ; Biological and medical sciences ; Bupivacaine - administration &amp; dosage ; Bupivacaine - adverse effects ; Bupivacaine - analogs &amp; derivatives ; Case-Control Studies ; Epidemiology ; Female ; Fundamental and applied biological sciences. Psychology ; Fundamental immunology ; General aspects ; Humans ; Infusions, Intralesional ; Kidney Transplantation ; Living Donors ; Male ; Medical sciences ; Middle Aged ; Pain Measurement ; Pain, Postoperative - prevention &amp; control ; Public health. Hygiene ; Public health. Hygiene-occupational medicine ; Retrospective Studies ; Surgery ; Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases ; Tissue, organ and graft immunology ; Treatment Outcome</subject><ispartof>Transplantation proceedings, 2009-05, Vol.41 (4), p.1128-1131</ispartof><rights>Elsevier Inc.</rights><rights>2009 Elsevier Inc.</rights><rights>2009 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c464t-97be450b527be1a16e4b38a4a795d469049d095ddbd4e3be65a30ef34defc1893</citedby><cites>FETCH-LOGICAL-c464t-97be450b527be1a16e4b38a4a795d469049d095ddbd4e3be65a30ef34defc1893</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.transproceed.2009.03.013$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>309,310,314,780,784,789,790,3550,23930,23931,25140,27924,27925,45995</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=21749685$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/19460497$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Sorbello, M</creatorcontrib><creatorcontrib>Paratore, A</creatorcontrib><creatorcontrib>Morello, G</creatorcontrib><creatorcontrib>Tindaro Sidoti, M</creatorcontrib><creatorcontrib>Rinzivillo, D</creatorcontrib><creatorcontrib>Molino, C</creatorcontrib><creatorcontrib>Di Tommaso, C</creatorcontrib><creatorcontrib>Parrinello, L</creatorcontrib><creatorcontrib>Veroux, P</creatorcontrib><creatorcontrib>Corona, D</creatorcontrib><creatorcontrib>Giuffrida, G</creatorcontrib><creatorcontrib>Zerbo, D</creatorcontrib><creatorcontrib>Veroux, M</creatorcontrib><title>Wound Levobupivacaine Continuous Infusion for Postoperative Analgesia in Living Kidney Donors: Case-Control Study</title><title>Transplantation proceedings</title><addtitle>Transplant Proc</addtitle><description>Abstract Introduction The objective of this study was to evaluate the efficacy of an analgesic regimen based on levobupivacaine continuous infusion into the surgical wound of living kidney donors (LKDs). Patients and Methods Fifty adult LKDs (mean age, 53.1 ± 5.3 years; age range, 52–68 years) were retrospectively assigned to a no wound infusion (NWI) group (n = 25) or a wound infusion (WI) group (n = 25). At the end of surgery, patients in the WI group received 10 mg intramuscular morphine; a peridural catheter was placed 10 cm between the intercostal muscles fibers close to the lower rib extremity, and a solution of levobupivacaine, 150 mg/100 mL, was started at 5 ml/h−1 . Patients in the NWI group received intramuscular morphine, 10 mg, every 8 hours; intravenous tramadole, 100 mg, was planned as a rescue drug for incidental pain. Pain was measured using a visual analog scale (VAS) ranging from 1 (no pain) to 10 (maximum pain) in both the basal condition (VASb) and during coughing (VASc) at 1 hour after leaving the operating room and 6, 12, and 24 hours thereafter. Results At 1, 6, 12, and 24 hours, VASb values in the NWI vs the WI group were 5.2 vs 3.1, 6.8 vs 4.1, 5.8 vs 4.9 (all p &lt; .01), and 5.4 vs 5.1, respectively, and VASc values were 8.2 vs 6.3, 8.8 vs 5.9, 7.1 vs 5.3, and 6.8 vs 5.1 (all p &lt; .01). Mean VAS score was significantly higher between 1 and 6 hours in the NWI group for all VASb measurements vs VASc values. Tramadole consumption was higher in the NWI group than in the WI group. Conclusions Continuous wound infusion with 5 mL/h−1 levobupivacaine, 1.5 mg/mL−1 , resulted in a safe and effective analgesic protocol in LKDs both in the immediate postoperative period and in the first day after surgery, a result that was more effective than a morphine-tramadole regimen. No adverse effects were recorded, which confirmed the safety of the technique. It is probable that better results could be achieved with dedicated administration devices.</description><subject>Adult</subject><subject>Aged</subject><subject>Anesthetics, Local - administration &amp; dosage</subject><subject>Anesthetics, Local - adverse effects</subject><subject>Biological and medical sciences</subject><subject>Bupivacaine - administration &amp; dosage</subject><subject>Bupivacaine - adverse effects</subject><subject>Bupivacaine - analogs &amp; derivatives</subject><subject>Case-Control Studies</subject><subject>Epidemiology</subject><subject>Female</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>Fundamental immunology</subject><subject>General aspects</subject><subject>Humans</subject><subject>Infusions, Intralesional</subject><subject>Kidney Transplantation</subject><subject>Living Donors</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Pain Measurement</subject><subject>Pain, Postoperative - prevention &amp; control</subject><subject>Public health. Hygiene</subject><subject>Public health. Hygiene-occupational medicine</subject><subject>Retrospective Studies</subject><subject>Surgery</subject><subject>Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases</subject><subject>Tissue, organ and graft immunology</subject><subject>Treatment Outcome</subject><issn>0041-1345</issn><issn>1873-2623</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2009</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNklGL1DAQx4so3nr6FSQIck9dJ03abu9BOPbUO1xQOEXfQppMj6zdZC_TFvbbm7LLcfjkUybMb_4z-Wey7B2HJQdefdguh6g97WMwiHZZADRLEEvg4lm24Kta5EVViOfZAkDynAtZnmWviLaQ7oUUL7Mz3sgKZFMvsodfYfSWbXAK7bh3kzbaeWTr4AfnxzASu_XdSC541oXIvgcawh6jHtyE7Mrr_h7JaeY827jJ-Xv21VmPB3YdfIh0ydaaMJ_VYujZ3TDaw-vsRad7wjen8zz7-fnTj_VNvvn25XZ9tcmNrOSQN3WLsoS2LFLANa9QtmKlpa6b0sqqSeNbSKFtrUTRYlVqAdgJabEzfNWI8-ziqJt8ehiRBrVzZLDvtcf0LlULwQHKSiTy8kiaGIgidmof3U7Hg-KgZsfVVj11XM2OKxAqOZ6K357ajO0u5R5LTxYn4P0J0GR03yUh4-iRK3gtm2pVJu76yGEyZXIYFRmH3qB1Ec2gbHD_N8_Hf2RM77xLnf_gAWkbxph-jRRXVChQd_OOzCsCTYoAfou_tQ-9Cg</recordid><startdate>20090501</startdate><enddate>20090501</enddate><creator>Sorbello, M</creator><creator>Paratore, A</creator><creator>Morello, G</creator><creator>Tindaro Sidoti, M</creator><creator>Rinzivillo, D</creator><creator>Molino, C</creator><creator>Di Tommaso, C</creator><creator>Parrinello, L</creator><creator>Veroux, P</creator><creator>Corona, D</creator><creator>Giuffrida, G</creator><creator>Zerbo, D</creator><creator>Veroux, M</creator><general>Elsevier Inc</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20090501</creationdate><title>Wound Levobupivacaine Continuous Infusion for Postoperative Analgesia in Living Kidney Donors: Case-Control Study</title><author>Sorbello, M ; Paratore, A ; Morello, G ; Tindaro Sidoti, M ; Rinzivillo, D ; Molino, C ; Di Tommaso, C ; Parrinello, L ; Veroux, P ; Corona, D ; Giuffrida, G ; Zerbo, D ; Veroux, M</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c464t-97be450b527be1a16e4b38a4a795d469049d095ddbd4e3be65a30ef34defc1893</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2009</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Anesthetics, Local - administration &amp; dosage</topic><topic>Anesthetics, Local - adverse effects</topic><topic>Biological and medical sciences</topic><topic>Bupivacaine - administration &amp; dosage</topic><topic>Bupivacaine - adverse effects</topic><topic>Bupivacaine - analogs &amp; derivatives</topic><topic>Case-Control Studies</topic><topic>Epidemiology</topic><topic>Female</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>Fundamental immunology</topic><topic>General aspects</topic><topic>Humans</topic><topic>Infusions, Intralesional</topic><topic>Kidney Transplantation</topic><topic>Living Donors</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Pain Measurement</topic><topic>Pain, Postoperative - prevention &amp; control</topic><topic>Public health. Hygiene</topic><topic>Public health. Hygiene-occupational medicine</topic><topic>Retrospective Studies</topic><topic>Surgery</topic><topic>Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases</topic><topic>Tissue, organ and graft immunology</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sorbello, M</creatorcontrib><creatorcontrib>Paratore, A</creatorcontrib><creatorcontrib>Morello, G</creatorcontrib><creatorcontrib>Tindaro Sidoti, M</creatorcontrib><creatorcontrib>Rinzivillo, D</creatorcontrib><creatorcontrib>Molino, C</creatorcontrib><creatorcontrib>Di Tommaso, C</creatorcontrib><creatorcontrib>Parrinello, L</creatorcontrib><creatorcontrib>Veroux, P</creatorcontrib><creatorcontrib>Corona, D</creatorcontrib><creatorcontrib>Giuffrida, G</creatorcontrib><creatorcontrib>Zerbo, D</creatorcontrib><creatorcontrib>Veroux, M</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Transplantation proceedings</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sorbello, M</au><au>Paratore, A</au><au>Morello, G</au><au>Tindaro Sidoti, M</au><au>Rinzivillo, D</au><au>Molino, C</au><au>Di Tommaso, C</au><au>Parrinello, L</au><au>Veroux, P</au><au>Corona, D</au><au>Giuffrida, G</au><au>Zerbo, D</au><au>Veroux, M</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Wound Levobupivacaine Continuous Infusion for Postoperative Analgesia in Living Kidney Donors: Case-Control Study</atitle><jtitle>Transplantation proceedings</jtitle><addtitle>Transplant Proc</addtitle><date>2009-05-01</date><risdate>2009</risdate><volume>41</volume><issue>4</issue><spage>1128</spage><epage>1131</epage><pages>1128-1131</pages><issn>0041-1345</issn><eissn>1873-2623</eissn><coden>TRPPA8</coden><abstract>Abstract Introduction The objective of this study was to evaluate the efficacy of an analgesic regimen based on levobupivacaine continuous infusion into the surgical wound of living kidney donors (LKDs). Patients and Methods Fifty adult LKDs (mean age, 53.1 ± 5.3 years; age range, 52–68 years) were retrospectively assigned to a no wound infusion (NWI) group (n = 25) or a wound infusion (WI) group (n = 25). At the end of surgery, patients in the WI group received 10 mg intramuscular morphine; a peridural catheter was placed 10 cm between the intercostal muscles fibers close to the lower rib extremity, and a solution of levobupivacaine, 150 mg/100 mL, was started at 5 ml/h−1 . Patients in the NWI group received intramuscular morphine, 10 mg, every 8 hours; intravenous tramadole, 100 mg, was planned as a rescue drug for incidental pain. Pain was measured using a visual analog scale (VAS) ranging from 1 (no pain) to 10 (maximum pain) in both the basal condition (VASb) and during coughing (VASc) at 1 hour after leaving the operating room and 6, 12, and 24 hours thereafter. Results At 1, 6, 12, and 24 hours, VASb values in the NWI vs the WI group were 5.2 vs 3.1, 6.8 vs 4.1, 5.8 vs 4.9 (all p &lt; .01), and 5.4 vs 5.1, respectively, and VASc values were 8.2 vs 6.3, 8.8 vs 5.9, 7.1 vs 5.3, and 6.8 vs 5.1 (all p &lt; .01). Mean VAS score was significantly higher between 1 and 6 hours in the NWI group for all VASb measurements vs VASc values. Tramadole consumption was higher in the NWI group than in the WI group. Conclusions Continuous wound infusion with 5 mL/h−1 levobupivacaine, 1.5 mg/mL−1 , resulted in a safe and effective analgesic protocol in LKDs both in the immediate postoperative period and in the first day after surgery, a result that was more effective than a morphine-tramadole regimen. No adverse effects were recorded, which confirmed the safety of the technique. It is probable that better results could be achieved with dedicated administration devices.</abstract><cop>Amsterdam</cop><pub>Elsevier Inc</pub><pmid>19460497</pmid><doi>10.1016/j.transproceed.2009.03.013</doi><tpages>4</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0041-1345
ispartof Transplantation proceedings, 2009-05, Vol.41 (4), p.1128-1131
issn 0041-1345
1873-2623
language eng
recordid cdi_proquest_miscellaneous_733100563
source MEDLINE; Access via ScienceDirect (Elsevier)
subjects Adult
Aged
Anesthetics, Local - administration & dosage
Anesthetics, Local - adverse effects
Biological and medical sciences
Bupivacaine - administration & dosage
Bupivacaine - adverse effects
Bupivacaine - analogs & derivatives
Case-Control Studies
Epidemiology
Female
Fundamental and applied biological sciences. Psychology
Fundamental immunology
General aspects
Humans
Infusions, Intralesional
Kidney Transplantation
Living Donors
Male
Medical sciences
Middle Aged
Pain Measurement
Pain, Postoperative - prevention & control
Public health. Hygiene
Public health. Hygiene-occupational medicine
Retrospective Studies
Surgery
Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases
Tissue, organ and graft immunology
Treatment Outcome
title Wound Levobupivacaine Continuous Infusion for Postoperative Analgesia in Living Kidney Donors: Case-Control Study
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T08%3A46%3A09IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Wound%20Levobupivacaine%20Continuous%20Infusion%20for%20Postoperative%20Analgesia%20in%20Living%20Kidney%20Donors:%20Case-Control%20Study&rft.jtitle=Transplantation%20proceedings&rft.au=Sorbello,%20M&rft.date=2009-05-01&rft.volume=41&rft.issue=4&rft.spage=1128&rft.epage=1131&rft.pages=1128-1131&rft.issn=0041-1345&rft.eissn=1873-2623&rft.coden=TRPPA8&rft_id=info:doi/10.1016/j.transproceed.2009.03.013&rft_dat=%3Cproquest_cross%3E733100563%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=733100563&rft_id=info:pmid/19460497&rft_els_id=S004113450900400X&rfr_iscdi=true